Press Release

CD BIOPARTICLES LAUNCHES NEW QUANTUM DOTS LABELING & CONJUGATION KITS



CD Bioparticles announced the launch of its new quantum dots labeling & conjugation kits for research usage.

FOR IMMEDIATE RELEASE

07/08/2023

With years of experience in the pharmaceutical and life science sectors, CD Bioparticles announced the launch of its new Quantum Dots Labeling & Conjugation Kits with highly efficient and site-specific labeling and conjugation capabilities, including Biotin QDs Conjugation Kits, Covalent QDs Antibody Labeling Kits, QDs Cell Labeling Kits and Streptavidin QDs Conjugation Kits.

Quantum dots (QDs) are semiconductor nanoparticles exhibiting size- and composition-dependent optical and electronic (photoelectronic) properties. They are extremely small, typically in the range of 1.5 to 10.0 nm. Recently, QD nanotechnology has been successfully introduced into numerous biomedical industries due to their unique properties, including excellent photostability, size-dependent optical properties, high extinction coefficient and brightness, and large Stokes shifts.

CD Bioparticles has developed a comprehensive list of DiagNano™ semiconductor QDs with various chemical compositions and surface functionalizations. These quantum dots have demonstrated uniform dimensions, tunable emission, high quantum yield and good thermal stability, making them suitable for high-sensitivity cell imaging, photovoltaic devices, solar cells and light-emitting devices.

To facilitate scientific research, CD Bioparticles now offers a range of quantum dots labeling and conjugation kits with highly efficient and site-specific labeling and conjugating capabilities, including Biotin QDs Conjugation Kits, Covalent QDs Antibody Labeling Kits, QDs Cell Labeling kits and Streptavidin QDs Conjugation Kits.

These new covalent quantum dot antibody labeling kits can attach QDs to the heavy chain of IgG antibodies, ensuring complete binding of the antigen-binding domain to antigenic target. Meanwhile, they contain all reagents needed in labeling process and allow scientists to finish labeling or conjugation by themselves following step-by-step protocol. For example, the QDs Cell Labeling Kit with excitation wavelength of 405 nm uses a custom targeting peptide to deliver fluorescent nanocrystals into the cytoplasm of living cells with an emission peak between 525 nm and 800 nm.

Another example is the Covalent QDs Antibody Labeling Kit with an excitation at 405/488 nm. It is highly efficient and site-specific labeling that attaches quantum dots to the heavy chains of an IgG antibody, ensuring that the antigen binding domains are intact for binding to the antigen target. One kit can label 100 μg of antibody with an emission peak between 525 nm and 800 nm.

CD Bioparticles also offers quantum dot cell labeling kits specifically designed for intracellular labeling. By using customized targeting peptides, fluorescent nanoparticles can be delivered into the cytoplasm of living cells. In addition, CD Bioparticles' streptavidin/biotin-linked quantum dot conjugation kits are useful tools for binding biotin probes or other biomolecules.

The kits are available now from CD Bioparticles. For more information, please visit https://www.cd-bioparticles.com/product/quantum-dots-labeling-conjugation-kits-list-212.html.

About CD Bioparticles

CD Bioparticles is a leading manufacturer and supplier of various nanoparticles, microparticles, and coatings for R&D as well as commercialization across different application areas, including in vitro diagnostics, biochemistry, cellular analysis, cell separation, and immunoassay. The company also offers various custom services, including chemical surface-functionalization, fluorescent modification, antibody immobilization, as well as nucleic acid and oligo conjugation to meet client specifications.

Tags:
Quantum Dots Labeling  |  CD Bioparticles  |  

---

Organisation Profile:
CD Bioparticles is an established drug delivery company which provides customized solutions for developing and producing new, biocompatible drug delivery systems.






Press release contact details for CD Bioparticles

NameCD Bioparticles
Tel1-631-346-0027
Fax
Email
Websitehttps://www.cd-bioparticles.net/
OrganisationCD Bioparticles
Address
Town
County0
Postcode




Other press releases from CD Bioparticles

CD Bioparticles Launches Gene Silencing for Bio-research Application
CD Bioparticles Launches Gel Permeation Chromatography Resins
CD Bioparticles Introduces Reversed Phase Chromatography Resins for Biological Analysis
CD Bioparticles Launches mRNA Transfection Reagents for Research Applications
CD Bioparticles Launches Normal Phase Chromatography Resins for Chromatographic Analysis
CD Bioparticles Launches 3D Transfection Reagents for Bio-research Applications
CD Bioparticles Launches Affinity Chromatography Resins for Laboratory Usage
CD Bioparticles Announces Carrageenans for Scientific Applications
CD Bioparticles Launches New Chromatography Resins for Improved Analysis and Preparation of Chiral Compounds
CD Bioparticles Launches New Alginic Acids for Research Applications
CD Bioparticles Launches Locust Bean Gum for Biopharmaceutical Applications
CD Bioparticles Announces New PLGA-Based Drug Delivery Systems for In Vitro and In Vivo Applications
CD Bioparticles Launches New Line of Bioinks for 3D Bioprinting
CD Bioparticles Launches New Quantum Dots Labeling & Conjugation Kits
CD Bioparticles Introduces New Extraction and Purification Kits for Rapid and Reliable DNA Isolation
CD Bioparticles Launches New Tissue Engineering Scaffolds for Researchers
CD Bioparticles Launches New Line of Polystyrene Particles Conjugated with Biomolecules
CD Bioparticles Launches 3D Cell Culture Substrate for Bio-research
CD Bioparticles Announces the Launch of New Flow Cytometry Particles
CD Bioparticles Introduces the Launch of Engineered Tissue Scaffolds
CD Bioparticles Announces Polyamino Acids for Drug Delivery Applications
CD Bioparticles Launches New Line of Functional Polystyrene Particles
CD Bioparticles Announces Expanded Offerings of Polydimethylsiloxane for Cutting-Edge Research
CD Bioparticles Unveils Versatile Plain Polystyrene Particles for Diverse Bioresearch Applications
CD Bioparticles Launches New Range of Low PDI Polymers for Drug Delivery Applications
CD Bioparticles Launches New Line of Particles for Solid Phase Organic Synthesis
CD Bioparticles Introduces Innovative Agarose Particles for Purification of Proteins and Antibodies
CD Bioparticles Announces New Line of Polyacrylamides for Drug Delivery Studies
CD Bioparticles Announces Versatile Basic Agarose Particles for Efficient Biomolecule Separation
CD Bioparticles Introduces New Polyolefin Family Polymers for Drug Delivery Applications
CD Bioparticles Announces New Line of Conjugated Agarose Particles for Affinity Separation and Purification
CD Bioparticles Announces Offering of Polystyrene Family Polymers for Drug Delivery
CD Bioparticles Announces Comprehensive Assay Portfolio for mRNA-LNP Vaccine Development
CD Bioparticles Introduces Functional Agarose Particles for Biomedical Research Applications
CD Bioparticles Announces Advanced Capabilities in Customized Liposomes for Targeted Delivery
CD Bioparticles Simplifies Multi-Analyte Detection with Advanced Multiplex Particles

Disclaimer:
Issuers of the press releases are solely responsible for the content of their press releases. Connect2business.co.uk cannot be held liable for the content posted by others to this website.